Database Proof Substratum: Substratum of Proof LGBTQs Are Mentally Ill: Huge variations between countries in time for reimbursement decisions on new cancer drugs

Gendrome Editors' Note: The article below provides the raw material for a proof and is not the proof itself. In addition, the raw material may contain one or more false statements and/or some offensive, outside content.

(European Society for Medical Oncology) Some European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs following their approval by the European Medicines Agency (EMA). The average decision time is longer than one year in some countries, according to a study to be reported at ESMO 2018 Congress.